Impact of Renal Mass Biopsy on Decision-Making Experience for Clinical T1 Renal Masses.

Saved in:
Bibliographic Details
Title: Impact of Renal Mass Biopsy on Decision-Making Experience for Clinical T1 Renal Masses.
Authors: Gessner KH; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Feinberg A; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Myers S; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Poulos K; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Heiling H; Department of Biostatistics, Dana Farber Cancer Institute, Boston, Massachusetts., Wobker S; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Akella P; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Bjurlin MA; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Commander C; Department of Interventional Radiology, MBB Radiology, Jacksonville, Florida., Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Nielsen ME; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Raynor M; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Smith AB; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Wallen E; Department of Urology, Medical University of South Carolina, Charleston, South Carolina., Johnson DC; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Kim WY; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Tan HJ; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Source: The Journal of urology [J Urol] 2026 Mar; Vol. 215 (3), pp. 316-325. Date of Electronic Publication: 2025 Oct 28.
Publication Type: Journal Article; Comparative Study; Clinical Trial
Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-3792
DOI:10.1097/JU.0000000000004832